PLAU directs conversion of fibroblasts to inflammatory cancer-associated fibroblasts, promoting esophageal squamous cell carcinoma progression via uPAR/Akt/NF-κB/IL8 pathway
Open Access
- 10 February 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cell Death Discovery
- Vol. 7 (1), 1-14
- https://doi.org/10.1038/s41420-021-00410-6
Abstract
Cancer-associated fibroblasts (CAFs) plays an important role in the tumor microenvironment. The heterogeneity of CAFs affects the effect of CAFs on promoting or inhibiting tumors, which can be regulated by other cells in the tumor microenvironment through paracrine methods. The urokinase-type plasminogen activator (PLAU) system mediates cell proliferation, migration, adhesion, and other functions through the proteolytic system, intracellular signal transduction, and chemokine activation. PLAU promotes tumor progression in many tumors. We explored the function of PLAU in ESCC and the influence of PLAU secreted by tumor cells on the heterogeneity of CAFs. We found that PLAU is highly expressed in ESCC, which is related to poor prognosis and can be used as a prognostic marker for ESCC. Through loss-of function and gain-of function experiments, we found that PLAU promoted ESCC proliferation and clone formation via MAPK pathway, and promotes migration by upregulating Slug and MMP9, which can be reversed by the MEK 1/2 inhibitor U0126. At the same time, through sequencing, cytokine detection, and RT-qPCR verification, we found that tumor cells secreted PLAU promoted the conversion of fibroblasts to inflammatory CAFs, which upregulated expression and secretion of IL8 via the uPAR/Akt/NF-kappa B pathway. The IL8 secreted by CAFs in turn promotes the high expression of PLAU in tumor cells and further promoted the progression of ESCC. In summary, PLAU was not only a prognostic marker of ESCC, which promoted tumor cell proliferation and migration, but also promoted the formation of inflammatory CAFs by the PLAU secreted by tumor cells.This publication has 50 references indexed in Scilit:
- Unraveling the therapeutic potential of the Hedgehog pathway in cancerNature Medicine, 2013
- Clinical significance of CXCL-8/CXCR-2 network in esophageal squamous cell carcinomaSurgery, 2013
- Tumour heterogeneity and cancer cell plasticityNature, 2013
- Inhibition of silibinin on migration and adhesion capacity of human highly metastatic breast cancer cell line, MDA-MB-231, by evaluation of β1-integrin and downstream molecules, Cdc42, Raf-1 and D4GDIMedical Oncology, 2011
- From Rous sarcoma virus to plasminogen activator, src oncogene and cancer managementOncogene, 2011
- Fibroblast-secreted hepatocyte growth factor plays a functional role in esophageal squamous cell carcinoma invasionProceedings of the National Academy of Sciences of the United States of America, 2010
- Regulation of cell signalling by uPARNature Reviews Molecular Cell Biology, 2010
- The Interleukin-8 Pathway in CancerClinical Cancer Research, 2008
- Gene Expression Profiling in Patients with Chronic Obstructive Pulmonary Disease and Lung CancerAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Activation of c-Raf-1 Kinase Signal Transduction Pathway in α7 Integrin-deficient MiceOnline Journal of Public Health Informatics, 1999